ArticleBMC musculoskeletal disorders2021
Validation and cross-cultural adaptation of the Korean translation of the Achilles tendon Total Rupture Score.
Article in BMC musculoskeletal disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 11 citations in OpenAlex.
- Early Structural Healing and 12-Month Clinical Outcomes of Atelocollagen Patch Augmentation for Achilles Tendon Repair: A Prospective Cohort Comparison.Clinics in orthopedic surgery · 2026Article
- Establishment of the Patient Acceptable Symptom State (PASS) for the Achilles Tendon Total Rupture Score in a Swedish Population.Orthopaedic journal of sports medicine · 2024Article
- The learning curve for minimally invasive Achilles repair using the "lumbar puncture needle and oval forceps" technique.BMC musculoskeletal disorders · 2024Article
- Conservative treatment outcome for Achilles tendon re-rupture occurring in the subacute phase after primary repair.Archives of orthopaedic and trauma surgery · 2024Article
- Validity and reliability of the Thai version of the Achilles tendon total rupture score.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023Article
- Cross-Culturally Adapted Versions of Patient Reported Outcome Measures for the Lower Extremity.International journal of sports physical therapy · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Achilles tendon Total Rupture Score (ATRS) is a widely used patient-reported outcome measure to assess clinical outcomes of Achilles tendon rupture, but it has not been validated in Korean yet. The purpose of this study was to translate the ATRS into Korean and evaluate its reliability and validity in a Korean population.
methodsThe ATRS was translated into Korean according to recommended guidelines for forward-backward translation. Thirty-eight patients who underwent surgical treatment for Achilles tendon rupture from 2017 to 2019 were enrolled. Reliability was evaluated by the intraclass correlation coefficient (ICC), standard error of measurement (SEM), and minimal detectable change (MDC). Construct validity was assessed with Spearman rank correlations with the Korean version of the Foot and Ankle Outcome Score (FAOS) and Numeric Rating Scale (NRS) for pain in daily activity.
resultsThe Korean translation of the ATRS had excellent test-retest reliability (ICC = 0.84) and acceptable internal consistency (Cronbach's alpha = 0.84). The SEM was 6.61, and the MDC was 18.32 at the individual level and 2.97 at the group level. The Korean translation of the ATRS was strongly correlated with the FASO (r = 0.88). Correlation with the NRS in daily activity (r = - 0.66) was moderate.
conclusionThe Korean translation of the ATRS showed sufficient reliability and validity for use in the Korean population. LEVEL OF EVIDENCE: II.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.